Search clinical trials for: cinacalcet hydrochloride

Total 7389 results

Amgen

Completed

Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis

Secondary Hyperparathyroidism, Chronic Kidney Disease

United States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
Amgen

Completed

ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism

Secondary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.

Completed

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

Secondary Hyperparathyroidism

China, Hong Kong, Korea, Republic of, Taiwan
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
University Hospital, Rouen
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Evaluation of a Cincalcet Suppression Test

Parathyroid Hormone Suppression Test With Cinacalcet

France
Amgen

Terminated

Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

Chronic Kidney Disease | Hyperparathyroidism, Secondary

United States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate

United States
Amgen

Completed

ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis

Cardiovascular Disease | Hyperparathyroidism | End Stage Renal Disease | Chronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Coronary Artery Calcification | Vascular Calcification | Kidney Disease | Calcification | Nephrology
Kyowa Kirin Co., Ltd.

Completed

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Primary Hyperparathyroidism | Parathyroid Carcinoma | Hypercalcemia

Japan
Amgen

Completed

SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism

End Stage Renal Disease | Secondary Hyperparathyroidism
Amgen

Completed

Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease (BONAFIDE)

Secondary Hyperparathyroidism

United States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
Tufts University

Completed

The Effect of Cinacalcet on Gastric Acid Output in Healthy Subjects

Healthy

United States
Seoul National University Hospital
Jeil-Kirin Pharmaceutical Inc.

Completed

Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level (CUPID)

Secondary Hyperparathyroidism

Korea, Republic of
Amgen

Completed

A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism

Hyperparathyroidism, Primary
Montefiore Medical Center

Terminated

Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients

Secondary Hyperparathyroidism | Hypercalcemia

United States
Papageorgiou General Hospital

Terminated

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Secondary Hyperparathyroidism

Greece
Amgen

Completed

A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)

Hyperparathyroidism, Primary
Amgen

Completed

Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis

Chronic Kidney Disease | Kidney Disease
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Completed

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT (ACTIVE)

Hyperparathyroidism; Secondary, Renal

China
Istituto Auxologico Italiano

Completed

Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism (CA-PHP)

Hyperparathyroidism, Primary | Osteoporosis

Italy
Amgen

Completed

Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

Secondary Hyperparathyroidism | Chronic Renal Insufficiency
Amgen

Completed

A Research Study for Patients With End-Stage Renal Disease (ESRD)

End Stage Renal Disease
Centre Hospitalier Universitaire Vaudois
Swiss National Science Foundation

Completed

Interaction Between a Calcimimetic Agent and the Renin Angiotensine Aldosterone System

Relationship Between Calcimimetic and the RAAS

Switzerland
ENRICO VERRINA

Unknown

Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)

Secondary Hyperparathyroidism

Italy
Vanderbilt University

Completed

Vitamin D, Insulin Resistance and Inflammation in ESRD

End Stage Renal Disease

United States
Amgen

Terminated

Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis

Chronic Kidney Disease, Secondary Hyperparathyroidism

United States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
Kyowa Kirin Co., Ltd.

Completed

Phase 2 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Penang Hospital, Malaysia
Ministry of Health, Malaysia

Unknown

Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients

Secondary Hyperparathyroidism

Malaysia
Amgen

Terminated

Pediatric Chronic Kidney Disease Safety and Efficacy

Hyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney Disease

United States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
Emory University
National Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation

Recruiting

Trikafta in Cystic Fibrosis Patients

Cystic Fibrosis

United States
Min-Sheng General Hospital
Taipei Medical University; Taipei Medical University Shuang Ho Hospital; National... and other collaborators

Completed

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Hyperparathyroidism; Secondary, Renal

Taiwan
City of Hope Medical Center
National Cancer Institute (NCI)

Suspended

Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma

United States
University of Washington
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

DePTH: De-emphasize PTH

Kidney Failure, Chronic | Chronic Kidney Disease-Mineral and Bone Disorder

United States
Peter Vestergaard
Aalborg University

Completed

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. (DENOCINA)

Primary Hyperparathyroidism | Parathyroid Adenoma | Parathyroid Hyperplasia

Denmark
University of Colorado, Denver

Completed

Trial to Optimize Mineral Outcomes in Dialysis Patients

Chronic Kidney Disease | Secondary Hyperparathyroidism

United States
Prof. Dominique de Quervain, MD
Clinical Trial Unit, University Hospital Basel, Switzerland

Completed

Influence of Cincalcet on Cognitive Functions in Healthy Human Subjects (Mira-Basel)

Memory Functions

Switzerland
Amgen

Completed

START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism

Chronic Kidney Disease | Secondary Hyperparathyroidism | Kidney Disease
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Amgen

Completed

PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice

Hyperparathyroidism, Primary
Amgen

Completed

Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels

End Stage Renal Disease
Neelesh Sharma MD PhD

Completed

Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Amgen

Completed

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

End Stage Renal Disease | Secondary Hyperparathyroidism
Amgen

Completed

Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)

End Stage Renal Disease
Children's Mercy Hospital Kansas City

Withdrawn

Calcimimetics in Hypophosphatemic Rickets (CHR)

Familial Hypophosphatemic Rickets

United States
Children's Mercy Hospital Kansas City

Completed

Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets

Hypophosphatemic Rickets, X-Linked Dominant

United States
Chinese University of Hong Kong

Completed

Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary Hyperparathyroidism

Hyperparathyroidism | Arterial Stiffness

Hong Kong
Seoul National University Hospital
Kyowa Hakko Kirin Pharma, Inc.; Jeil-Kirin Pharmaceutical Inc.

Completed

Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493

Healthy

Korea, Republic of
Xijing Hospital of Digestive Diseases

Completed

A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer

Colorectal Adenomas

China
Xijing Hospital of Digestive Diseases

Completed

Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride

Colorectal Adenomas

China
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet

Uremic Pruritus

China

Search clinical trials for: cinacalcet hydrochloride

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations